EDGEWISE THERAPEUTICS INC (EWTX)

US28036F1057 - Common Stock

19.52  +0.23 (+1.19%)

After market: 19.52 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
114.36M71.66M43.22M17.19M9.92M
Research and Development
90.91M54.03M32.19M14.98M8.62M
Selling, General, and Administrative Expenses
23.45M17.63M11.03M2.21M1.30M
Operating Income
-114.36M-71.66M-43.22M-17.19M-9.92M
Interest Income/Expense
14.19M4.02M400.00K70.00K220.00K
Income Before Taxes
-100.16M-67.64M-42.81M-17.12M-9.71M
Net Income
-100.16M-67.64M-42.81M-17.12M-9.71M
EBITDA
-112.81M-71.29M-42.95M-17.00M-9.80M
 
Per Share Data
EPS Diluted Total Ops
-1.57-1.26-1.14-0.36-0.20
Non GAAP EPS
-1.58-1.27-0.87N/AN/A
 
Statistics

All data in USD

Charts